CPT-417

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCPT-417
Drug Alias Namecamptothecin analog (CEPTYR/California Pacific/St Mary's)camptothecin analog (CEPTYR/CPMC/SMMC)CPT-417
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWorld
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalifornia Pacific Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalifornia Pacific Medical CenterCEPTYR Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A